Lysosomotropic amines can stimulate the function of NPC1 in the clearance of lysosomal contents and late endosome/lysosome hybrid organelle formation. A, cumulative lysosomal-dextran secreted into the cell culture medium after 24 h in both NPC1+/+ and NPC1-/- fibroblasts pretreated with indicated molecules. Bars represent average ± S.D. for the percent deviation in dextran amount released relative to untreated NPC1+/+ fibroblasts (value set to zero). Positive differences in dextran release were observed for the lysosomotropic amines neutral red (70 μm, NR, n = 12), morpholine (10 mm, MOR, n = 8), and imidazole (10 mm, IMDZ, n = 7) in NPC1+/+ fibroblasts relative to the untreated control (*, p < 0.001 by unpaired t test). Statistical differences were not observed in NPC1-/- cells treated with the same compounds. Amine-containing molecules that are known not to accumulate in the lysosome, such as rhodamine-123 (R123, 70 μm, n = 7), had no effect on dextran release. U18666A (10 μm, n = 7) inhibited NPC1 function in dextran secretion in normal cells and had no influence on NPC cells. The formation of sucrosomes with sucrose (0.1% w/v, n = 4) had no statistically significant influence of dextran secretion. B, the degree of late endosome/lysosome hybrid organelle formation in NPC1+/+ and NPC1-/- fibroblasts pretreated with indicated molecules. Bars represent average ± S.D. for the percent deviation in FRET signal relative to untreated NPC1+/+ fibroblasts (value set to zero). Positive deviations in hybrid organelle formation (relative to untreated normal fibroblasts) were observed for MOR (5 mm, n = 3) and IMDZ (10 mm, n = 3) with NPC1+/+ fibroblasts. Treatments with U18666A (10 μm, n = 3) and nocodazole (50 μm, n = 3) decreased late endosome/lysosome fusion relative to control using NPC1+/+ fibroblasts (*, p < 0.01 by unpaired t test). All treatments using NPC1-/- fibroblasts (n = 3 for each) showed no differences in FRET signal in comparison to untreated NPC1-/- fibroblasts.